Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): C Noah Nilsson , Mads Kristian Ersbøll , Finn Gustafsson Added: 10 months ago

Heart Failure
Research Area(s) / Expertise:
Job title: Director
Andrew Mente
Job title: Associate Professor – Department of Health Research Methods, Evidence, and Impact (HEI)
Dr Andrew Mente is a Principal Investigator for the Epidemiology program at the Population Health Research Institute and Associate Professor – Department of Health Research Methods, Evidence, and Impact (HEI), McMaster University. Dr Mente received his doctoral degree in Epidemiology from the University of Toronto and completed post-doctoral training in cardiovascular epidemiology at McMaster… View more
EASD 23: Efinopegdutide in NAFLD & T2D patients
Author(s): Samuel S Engel Added: 1 year ago
EASD 2023 — In this short interview, Dr Samuel S Engel (Associate Vice President at Merck) discusses a study investigating the effectiveness and safety of efinopegdutide (MK-6024) in patients with nonalcoholic fatty liver disease and type 2 diabetes (NCT04944992).The phase IIa study randomized 145 participants (efinopegdutide, n = 72; semaglutide, n = 73). The majority (55.2%) of participants… View more

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
David Wheeler
Research Area(s) / Expertise:

Chronic Kidney Disease

 Job title: Professor of Kidney Medicine
David Wheeler is Professor of Kidney Medicine at University College London and Honorary Consultant Nephrologist at the Royal Free London NHS Foundation Trust.Prof Wheeler is a clinician scientist interested in the complications of chronic kidney disease (CKD), specifically those that increase the burden of cardiovascular disease and/or accelerate progression of kidney failure. He has participated… View more
Author(s): Antonio Ceriello , Ileana L Piña , Gianluigi Savarese , et al Start date: Mar 23, 2024

Heart Failure

Prevention & Chronic Conditions
Author(s): Antonio Ceriello , Ileana L Piña , Gianluigi Savarese , et al Start date: Mar 22, 2024

Heart Failure

Prevention & Chronic Conditions
CardioNerds @AHA23: Presidential Advisory on CKM Health
Author(s): Ramy Doss , Chiadi Ndumele Added: 1 year ago
AHA 2023 — CardioNerds Ambassador, Dr Ramy Doss (Nazareth Hospital, US) is joined by Dr Chiadi E Ndumele (Johns Hopkins University, US) to talk about AHA's Presidential Advisory on Cardiovascular-Kidney-Metabolic Health (CKM).The presidential advisory focuses on the cardiovascular-kidney-metabolic (CKM) syndrome, a systemic disorder connecting heart disease, kidney disease, diabetes and obesity… View more

Guidelines & Statements

Prevention & Chronic Conditions
Emerging Strategies in Aldosterone Inhibition: A Special Focus
Author(s): Vijay Chopra Added: 1 month ago
Guest Editor Dr Vijay Chopra discusses the motivation behind the newly curated Special Focus on mineralocorticoid receptor antagonists.Dr Chopra explores why this topic is more relevant than ever, particularly as the field moves beyond traditional aldosterone antagonists toward novel agents like finerenone and aldosterone synthase inhibitors.From addressing hyperkalaemia fears to identifying gaps… View more

Heart Failure